Editors’ Picks, February 2026: FDA’s Accelerated Approval Pathway, Overcoming Resistance to KRAS Inhibition, and More
In February, the editors of AACR's journals highlighted studies on the FDA’s accelerated approval pathway, how metabolism impacts prostate...









